Alzamend Neuro (ALZN) Non Operating Interest Expenses (2020 - 2026)
Alzamend Neuro (ALZN) recorded Non Operating Interest Expenses of $2,005 in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 19.3% from $2,483 a year earlier.
Alzamend Neuro (ALZN) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's Non Operating Interest Expenses came in at $6,141 as of Jul 31, 2026, down 27.8% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $6,619, down 63.3% from FY2025.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -45.9% (FY2021 to FY2026).
- Across earlier fiscal years, Non Operating Interest Expenses came in at $18,029 in FY2025 (+78.5%), $10,101 in FY2024 (+31.2%), $7,701 in FY2023 (-83.4%) and $46,524 in FY2022 (-67.3%).
- Quarterly Non Operating Interest Expenses has ranged from $150.00 in fiscal Q4 2026 to $16,299 in fiscal Q3 2022 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses has declined for eight consecutive quarters, with an average decline of 41.3% over the last eight quarters.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 554.3% in fiscal Q1 2025, against a decline of 98.2% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $150.00 (Q4 2026), $1,337 (Q3 2026) and $2,649 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Alzamend Neuro | 6.37 Mn | 6.37 Mn | - | 2,005.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2,005.00 |
| Apr 30, 2026 | 150.00 |
| Jan 31, 2026 | 1,337.00 |
| Oct 31, 2025 | 2,649.00 |
| Jul 31, 2025 | 2,483.00 |
| Apr 30, 2025 | 509.00 |
| Jan 31, 2025 | 2,019.00 |
| Oct 31, 2024 | 3,495.00 |
| Jul 31, 2024 | 12,006.00 |
| Apr 30, 2024 | 1,465.00 |
| Jan 31, 2024 | 2,488.00 |
| Oct 31, 2023 | 4,311.00 |
| Jul 31, 2023 | 1,835.00 |
| Apr 30, 2023 | 519.00 |
| Jan 31, 2023 | 2,062.00 |
| Oct 31, 2022 | 3,588.00 |
| Jul 31, 2022 | 1,532.00 |
| Apr 30, 2022 | 602.00 |
| Jan 31, 2022 | 16,299.00 |
| Oct 31, 2021 | 15,995.00 |
Alzamend Neuro Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();